NA
NVO

Nordwand Advisors’s Novo Nordisk NVO Stock Holding History

Nordwand Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-86
Closed -$8.9K – 170
2023
Q4 		$8.9K Buy
+86
New +$8.51K ﹤0.01% 118
2023
Q1 		– Sell
-14,838
Closed -$1M – 133
2022
Q4 		$1M Buy
+14,838
New +$870K 0.13% 39

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nordwand Advisors's NVO Position: Q1 2024 in Review

Nordwand Advisors sold out of Novo Nordisk (NVO) in Q1 2024, closing a stake of 86 shares — an estimated $8.9K sold.

Nordwand Advisors first reported a position in NVO in Q4 2022 and held it in 2 quarters. The position peaked at $1M in Q4 2022. 1,744 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • Nordwand Advisors reported no remaining Novo Nordisk position as of Q1 2024 after selling out during the quarter.
  • Nordwand Advisors sold 86 Novo Nordisk shares in Q1 2024, an estimated $8.9K.
  • Nordwand Advisors first reported a position in Novo Nordisk in Q4 2022 and held it in 2 quarters.
  • Nordwand Advisors's Novo Nordisk position peaked at $1M in Q4 2022.
  • 1,744 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Nordwand Advisors's 13F filing for Q1 2024, filed 6 May 2024.